ArticlePloS one2024

Low dose TamOxifen and LifestylE changes for bReast cANcer prevention (TOLERANT study): Study protocol of a randomized phase II biomarker trial in women at increased risk for breast cancer.

Aliana Guerrieri-Gonzaga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.